Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Kezar Life Sciences Inc. KZR

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program.


Top institutional share ownership of Kezar Life Sciences Inc

Name Shares Shares % change Value Value % change
Suvretta Capital Management, Llc 4,412,300 212.9% $36,490 55.7%
Avidity Partners Management LP 4,050,000 15.1% $33,494 -42.7%
BlackRock Inc. 3,579,790 23.6% $29,605 -38.5%
Bellevue Group AG 3,035,000 -35.0% $25,099 -67.7%
Victory Capital Management Inc 2,770,098 58.1% $22,909 -21.4%
Millennium Management Llc 2,748,946 198.1% $22,734 48.4%
Vanguard Group Inc 2,437,187 9.4% $20,154 -45.6%
Marshall Wace, Llp 1,908,515 319.0% $15,783 108.5%
CHI Advisors LLC 1,840,793 485.1% $15,223 191.1%
Point72 Asset Management, L.P. 1,608,400 -29.0% $13,301 -64.7%

Top institutional buyers of Kezar Life Sciences Inc

Name Shares % change Value % change Shares Value
Jpmorgan Chase & Co 1626.9% 759.4% 1,101,536 $9,110
CHI Advisors LLC 485.1% 191.1% 1,840,793 $15,223
Prosight Management, LP 320.9% 109.4% 1,262,691 $10,442
Marshall Wace, Llp 319.0% 108.5% 1,908,515 $15,783
Suvretta Capital Management, Llc 212.9% 55.7% 4,412,300 $36,490
Millennium Management Llc 198.1% 48.4% 2,748,946 $22,734
XBI - SPDR(R) S&P(R) Biotech ETF 116.8% 115.5% 1,532,671 $25,473
Northern Trust Corp 111.8% 5.4% 926,519 $7,662
Victory Capital Management Inc 58.1% -21.4% 2,770,098 $22,909
Ikarian Capital, LLC 30.0% -35.3% 1,408,116 $11,645

Top institutional sellers of Kezar Life Sciences Inc

Name Shares % change Value % change Shares Value
Franklin Resources Inc -45.1% -72.7% 1,365,323 $11,291
Logos Global Management LP -41.1% -70.7% 950,000 $7,857
Bellevue Group AG -35.0% -67.7% 3,035,000 $25,099
Point72 Asset Management, L.P. -29.0% -64.7% 1,608,400 $13,301
FBDIX - Franklin Biotechnology Discovery Fund Class A -0.8% -10.6% 846,450 $10,056

Information provided by Fintel.io